31results about How to "Solve the problem of ischemia and hypoxia" patented technology

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition follows principles of reinforcing intestinal epithelial goblet cells, building a normal intestinal surface mucous layer barrier, preventing an antigen approaching, touching, adhering to and entering an intestinal wall, and then blocking an abnormal immune response and the occurrence of inflammation. In the composition, ganoderma and radix salviae miltiorrhizae have efficacies of strengthening blood supply and oxygen supply to the human body; threonine is a component of mucoprotein; glutamine is a main energy source of intestinal mucosa. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of the goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of building the normal intestinal surface mucous layer barrier for the human body, eliminating inflammation and repairing intestinal tissues, and is used for effectively treating the inflammatory bowel disease.

The invention discloses a prescription for treating inflammatory bowel disease and belongs to the field of medicines. The prescription is prepared from lucid ganoderma, salvia miltiorrhiza, tuckahoe, glutamine, threonine, serine and cysteine; the lucid ganoderma, the salvia miltiorrhiza and the tuckahoe have effects of enhancing blood supply and oxygen supply of a human body; the glutamine is used as a main energy source of intestinal mucosa; the threonine, the serine and the cysteine are used as components of mucoprotein. The prescription disclosed by the invention provides nutrition, oxygen and raw materials for generation, renewal and repair of goblet cells and an intestinal surface mucous layer barrier formed by mucoprotein secreted by the goblet cells; the prescription has significant effects for terminating inflammation, repairing intestinal tissues and constructing a normal intestinal surface mucous layer barrier of the human body, and is an effective prescription for treating the inflammatory bowel disease.

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises ganoderma, radix salviae miltiorrhizae, poria cocos, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene, wherein ganoderma, radix salviae miltiorrhizae and poria cocos have efficacies of strengthening blood supply and oxygen supply to the human body; threonine, serine and cysteine are components of mucoprotein; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.

The invention discloses an eleventh formula for treating inflammatory bowel disease, and belongs to the field of medicine. The formula comprises the components of salvia miltiorrhiza, threonine, vitamin C, vitamin E, vitamin A and beta-carotene. Salvia miltiorrhiza has the efficacies of enhancing human blood supply and oxygen supply; threonine is a constituent part of mucoproteins; vitamin C, vitamin E, vitamin A and beta-carotene have the effects of blocking and inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals and protecting human body cells. The formula provides nutrients, oxygen and raw materials for generation, updating and repairing of goblet cells and for goblet cell secreting of the mucoproteins to construct an intestinal surface mucous layer barrier. The formula has obvious effects on terminating inflammation, repairing intestinal tissues and building the human body normal intestinal surface mucus layer barrier, and is an effective formula for treating inflammatory bowel disease.

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition follows principles of reinforcing intestinal tissue cells, building a normal intestinal surface mucous layer barrier, preventing an antigen approaching, touching, adhering to and entering an intestinal wall, and then blocking an abnormal immune response and the occurrence of inflammation. In the composition, ganoderma and radix salviae miltiorrhizae have efficacies of strengthening blood supply and oxygen supply to the human body; glutamine is a main energy source of intestinal mucosa; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of building the normal intestinal surface mucous layer barrier for the human body, eliminating inflammation and repairing intestinal tissues, and is used for effectively treating the inflammatory bowel disease.

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises ganoderma, radix salviae miltiorrhizae, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene, wherein ganoderma and radix salviae miltiorrhizae have efficacies of strengthening blood supply and oxygen supply to the human body; threonine, serine and cysteine are components of mucoprotein; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.

The invention discloses a composition for treating inflammatory bowel disease and belongs to the field of medicines. The composition comprises the following components: salvia miltiorrhiza, glutamine, threonine, serine, cysteine, vitamins C, E and A, and beta-carotene. The salvia miltiorrhiza has the efficacy of enhancing blood supply and oxygen supply of human bodies; glutamine is a main energy source for the intestinal mucosa; threonine, serine and cysteine are main components of mucoprotein; the vitamins C, E and A and beta-carotene have the effects of inhibiting activity of oxygen free radicals, removing oxygen free radicals and protecting human cells. The composition disclosed by the invention provides nutrients, oxygen and raw materials for goblet cells for development, renewal and repairing as well as secretion of mucoprotein to form the intestinal surface mucous layer barrier. The composition has an obvious effect for termination of inflammation, repairing of intestinal tissue and establishment of the normal intestinal surface mucous layer barrier of a human body and is an effective composition for treating the inflammatory bowel disease.

The invention discloses a composition for treating the inflammatory bowel disease, and belongs to the field of medicines. Intestinal epidermal goblet cells are reinforced to construct a normal intestinal surface mucus layer barrier in order to prevent intestinal antigens from approaching, contacting, adhering and entering intestine wall tissues, so abnormal immune response and inflammation generation are blocked out. Salvia miltiorrhiza has the efficacy of enhancing human body blood supply and oxygen supply; threonine is a composition part of mucoproteins, and is an essential amino acid in human bodies; and glutamine is the main energy source of intestinal mucosa. The composition provides nutrition, oxygen and raw materials for generation, updating and restoration of goblet cells and an intestinal tract surface mucus layer barrier composed of mucoproteins secreted by the goblet cells. The composition obtained through combining Salvia miltiorrhiza, ginseng and glutamine has obvious inflammation termination, intestinal tract tissue restoration and human body normal intestinal tract surface mucus layer barrier construction effects, and is an effective formula for treating the inflammatory bowel disease.

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises ginseng, glutamine, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene, wherein ginseng has efficacies of strengthening blood supply and oxygen supply to the human body; glutamine is a main energy source of intestinal mucosa; threonine, serine and cysteine are components of mucoprotein; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.

The invention discloses a formula for treating inflammatory bowel disease, and belongs to the field of drugs. The formula of the invention follows the principles of reinforcing intestinal epithelial goblet cells, building a normal intestinal surface mucous layer barrier and preventing intestine antigen from approaching, getting into contact with, adhering to and entering an intestinal wall tissue, so as to block abnormal immune response and the happening of inflammation. Radix salviae miltiorrhizae has functions of enhancing blood supply and oxygen supply of a human body; glutamine serves as a main energy source of intestinal mucosa; and threonine, serine and cysteine are main constituent parts of mucoprotein. The formula of the invention can provide nutrition, oxygen and raw materials for the generation, renewal and repair of goblet cells and for the secretion of the mucoprotein from the goblet cells to form an intestinal surface mucous layer barrier. The formula of the invention, as an effective formula for treating inflammatory bowel disease, takes significant effects on terminating inflammation, repairing intestinal structure and building the normal intestinal surface mucous layer barrier of the human body.

The invention discloses a composition for treating inflammatory bowel diseases, belonging to the field of medicines. The composition is prepared from the following components: lucid ganoderma, radix salviae miltiorrhizae, poria cocos, glutamine, threonine, serine, cysteine, vitamins C, E and A, and beta-carotene. Lucid ganoderma, radix salviae miltiorrhizae and poria cocos have the efficacy of boosting the blood supply and the oxygen supply for the human body; glutamine is the major energy source of the intestinal mucosa; threonine, serine and cysteine are the constituent parts of mucoprotein; vitamins C, E and A, and beta-carotene have the effects of suppressing the activity of oxygen free radicals, eliminating the oxygen free radicals, and protecting the human cells. The composition provides nutrition, oxygen and raw materials for the generation, renewing and repair of goblet cells, and the process that the goblet cells secrete mucoprotein to form a slime layer barrier for the surface of the intestinal tract. The composition has obvious effects in terminating the inflammation, repairing the intestinal tissue, and establishing the normal slime layer barrier for the surface of the human intestinal tract, and belongs to an effective composition for treating the inflammatory bowel diseases.

The invention discloses a composition for treating an inflammatory bowel disease and belongs to the field of medicines. The composition comprises ganoderma lucidum, glutamine, threonine, serine, cysteine, vitamins C, E and A and beta-carotene. The ganoderma lucidum has the effects of enhancing blood supply and oxygen supply for a human body. The glutamine is main energy source of the intestinal mucosa. The threonine, the serine and the cysteine are the main constituent parts of mucoprotein. The vitamins C, E and A and the beta-carotene have the effects of inhibiting the oxygen free radical activity, removing oxygen free radicals and protecting human body cells. The composition provides nutrients, oxygen and raw materials for development, update and repair of goblet cells and composition of an intestinal tract surface mucous layer barrier by goblet cell secretory mucoprotein. The composition has the obvious effects of eliminating inflammation, repairing intestinal tissues and establishing the normal intestinal tract surface mucous layer barrier of the human body and is an effective formula for treatment of the inflammatory bowel disease.

The invention discloses a formula for treating inflammatory bowel disease, and belongs to the field of drugs. The formula consists of ginseng, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene. The ginseng has functions of enhancing blood supply and oxygen supply of a human body; the threonine, the serine and the cysteine are main constituent parts of mucoprotein; and the vitamin C, the vitamin E, the vitamin A and the beta-carotene have functions of depressing the activity of oxygen radical, eliminating the oxygen radical and protecting body cells. The formula of the invention can provide nutrition, oxygen and raw materials for the generation, renewal and repair of goblet cells and for the secretion of the mucoprotein from the goblet cells to form an intestinal surface mucous layer barrier. The formula of the invention, as an effective formula for treating inflammatory bowel disease, takes significant effects on terminating inflammation, repairing intestinal structure and building the normal intestinal surface mucous layer barrier of the human body.

The invention discloses a prescription for treating inflammatory bowel disease and belongs to the field of medicines. The prescription is prepared from lucid ganoderma, salvia miltiorrhiza, tuckahoe, vitamin C, vitamin E, vitamin A and beat-carotene; the lucid ganoderma, the salvia miltiorrhiza and the tuckahoe have effects of enhancing blood supply and oxygen supply of a human body; the vitamin C, the vitamin E, the vitamin A and the beat-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals and protecting human body cells. The prescription disclosed by the invention provides nutrition, oxygen and raw materials for generation, renewal and repair of goblet cells and an intestinal surface mucous layer barrier formed by mucoprotein secreted by the goblet cells; the prescription has significant effects for terminating inflammation, repairing intestinal tissues and constructing a normal intestinal surface mucous layer barrier of the human body, and is an effective prescription for treating the inflammatory bowel disease.

The invention discloses a combination formula for treating the inflammatory bowel disease, and belongs to the field of medicines. The formula comprises Mythic Fungus, Salvia miltiorrhiza, ginseng, Poria cocos, glutamine, threonine, serine and cysteine. Mythic Fungus, Salvia miltiorrhiza, ginseng and Poria cocos have the efficacy of enhancing human body blood supply and oxygen supply; glutamine is the main energy source of intestinal mucosa; and threonine, serine and cysteine are composition parts of mucoproteins. The combination formula provides nutrition, oxygen and raw materials for generation, updating and restoration of goblet cells and an intestinal tract surface mucus layer barrier composed of mucoproteins secreted by the goblet cells. The combination formula has obvious inflammation termination, intestinal tract tissue restoration and human body normal intestinal tract surface mucus layer barrier construction effects, and is an effective composition for treating the inflammatory bowel disease.

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises ganoderma, poria cocos, glutamine, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene, wherein ganoderma and poria cocos have efficacies of strengthening blood supply and oxygen supply to the human body; glutamine is a main energy source of intestinal mucosa; threonine, serine and cysteine are components of mucoprotein; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.

The invention discloses a formula for treating inflammatory bowel disease, and belongs to the field of drugs. The formula of the invention follows the principles of reinforcing intestinal epithelial goblet cells, building a normal intestinal surface mucous layer barrier and preventing intestine antigen from approaching, getting into contact with, adhering to and entering an intestinal wall tissue, so as to block abnormal immune response and the happening of inflammation. Radix salviae miltiorrhizae has functions of enhancing blood supply and oxygen supply of a human body; and glutamine serves as a main energy source of intestinal mucosa. The formula of the invention can provide nutrition, oxygen and raw materials for the generation, renewal and repair of goblet cells and for the secretion of mucoprotein from the goblet cells to form an intestinal surface mucous layer barrier. The formula of the invention, as an effective formula for treating inflammatory bowel disease, takes significant effects on terminating inflammation, repairing intestinal structure and building the normal intestinal surface mucous layer barrier of the human body.

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition follows principles of reinforcing intestinal epithelial goblet cells, building a normal intestinal surface mucous layer barrier, preventing an antigen approaching, touching, adhering to and entering an intestinal wall, and then blocking an abnormal immune response and the occurrence of inflammation. In the composition, ganoderma and radix salviae miltiorrhizae have efficacies of strengthening blood supply and oxygen supply to the human body; glutamine is a main energy source of intestinal mucosa. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of the goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of building the normal intestinal surface mucous layer barrier for the human body, eliminating inflammation and repairing intestinal tissues, and is used for effectively treating the inflammatory bowel disease.

The invention discloses a prescription for treating inflammatory bowel disease and belongs to the field of medicines. The prescription is prepared from lucid ganoderma, threonine, serine and cysteine, vitamin C, vitamin E, vitamin A and beat-carotene; the lucid ganoderma has effects of enhancing blood supply and oxygen supply of a human body; the threonine, the serine and the cysteine are used as main components of mucoprotein; the vitamin C, the vitamin E, the vitamin A and the beat-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals and protecting human body cells. The prescription disclosed by the invention provides nutrition, oxygen and raw materials for generation, renewal and repair of goblet cells and an intestinal surface mucous layer barrier formed by mucoprotein secreted by the goblet cells; the prescription has significant effects for terminating inflammation, repairing intestinal tissues and constructing a normal intestinal surface mucous layer barrier of the human body, and is an effective prescription for treating the inflammatory bowel disease.

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises ganoderma, radix salviae miltiorrhizae, ginseng, threonine, serine and cysteine, wherein ganoderma, radix salviae miltiorrhizae and ginseng have efficacies of strengthening blood supply and oxygen supply to the human body; threonine, serine and cysteine are components of mucoprotein. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.

The invention discloses a combined formulation for treating inflammatory bowel diseases and belongs to the field of medicine. The combined formulation is composed of Ganoderma lucidum, Salvia miltiorrhiza, glutamine, threonine, serine cysteine, vitamins C, E and A and beta-carotene. Ganoderma lucidum and Salvia miltiorrhiza have efficacy of enhancing human blood supply and oxygen supply, glutamine is a main energy source of intestinal mucosa, threonine, serine and cysteine are main components of mucoprotein, and the vitamins C, E and A and beta-carotene has effects of inhibiting oxygen radical activity, eliminating oxygen radicals and protecting human cells. The combined formulation provides nutrition, oxygen and raw materials for generation, updating and restoring of goblet cells and to the goblet cells to secrete mucoprotein to form intestinal tract surface mucous layer barriers. The combined formulation has obvious effect on stopping inflammation, restoring intestinal tract tissue and building normal human intestinal tract surface mucous layer barriers and is an effective composition for treating the inflammatory bowel diseases.

The invention discloses a composition for treating an inflammatory bowel disease and belongs to the field of medicines. The composition comprises ganoderma lucidum, salvia miltiorrhiza, ginsengs, poria cocos, vitamins C, E and A and beta-carotene. The ganoderma lucidum, the salvia miltiorrhiza, the ginsengs and the poria cocos have the effects of enhancing blood supply and oxygen supply for a human body. The vitamins C, E and A and the beta-carotene have the effects of inhibiting the oxygen free radical activity, removing oxygen free radicals and protecting human body cells. The composition provides nutrients, oxygen and raw materials for development, update and repair of goblet cells and composition of an intestinal tract surface mucous layer barrier by goblet cell secretory mucoprotein. The composition has the obvious effects of eliminating inflammation, repairing intestinal tissues and establishing the normal intestinal tract surface mucous layer barrier of the human body and is an effective formula for treatment of the inflammatory bowel disease.

The invention discloses a combined formula for treating inflammatory bowel disease, and belongs to the field of drugs. The formula consists of lucid ganoderma, radix salviae miltiorrhizae, threonine, vitamin C, vitamin E, vitamin A and beta-carotene. The lucid ganoderma and the radix salviae miltiorrhizae have functions of enhancing blood supply and oxygen supply of a human body; the threonine is a constituent part of mucoprotein; and the vitamin C, the vitamin E, the vitamin A and the beta-carotene have functions of depressing the activity of oxygen radical, eliminating the oxygen radical and protecting body cells. The formula of the invention can provide nutrition, oxygen and raw materials for the generation, renewal and repair of goblet cells and for the secretion of the mucoprotein from the goblet cells to form an intestinal surface mucous layer barrier. The formula of the invention, as an effective formula for treating inflammatory bowel disease, takes significant effects on terminating inflammation, repairing intestinal structure and building the normal intestinal surface mucous layer barrier of the human body.

The invention discloses a combination formula for treating the inflammatory bowel disease, and belongs to the field of medicines. Intestinal epidermal goblet cells are reinforced to construct a normal intestinal surface mucus layer barrier in order to prevent intestinal antigens from approaching, contacting, adhering and entering intestine wall tissues, so abnormal immune response and inflammation generation are blocked out. Salvia miltiorrhiza has the efficacy of enhancing human body blood supply and oxygen supply; and threonine is a composition part of mucoproteins, and is an essential amino acid in human bodies. The formula provides nutrition, oxygen and raw materials for generation, updating and restoration of goblet cells and an intestinal tract surface mucus layer barrier composed of mucoproteins secreted by the goblet cells. The formula obtained by combining Salvia miltiorrhiza with threonine has obvious inflammation termination, intestinal tract tissue restoration and human body normal intestinal tract surface mucus layer barrier construction effects, and is an effective formula for treating the inflammatory bowel disease.

The invention discloses a combined formula for treating inflammatory bowel disease, and belongs to the field of medicine. The combined formula is a formula with the principle of reinforcing intestinal epithelia goblet cells, building a normal intestinal surface mucous layer barrier, preventing intestinal antigens from being close to, making contact with, adhering to and going into intestinal wall tissues, so as to block the occurrence of abnormal immune response and inflammation. Ganoderma lucidum and salvia miltiorrhiza have the efficacies of enhancing human body blood supply and oxygen supply; threonine is a constituent part of mucoproteins and is also a human body essential amino acid. The formula provides nutrients, oxygen and raw materials for generation, updating and repairing of the goblet cells and for goblet cell secreting of the mucoproteins to construct the intestinal surface mucous layer barrier. The three-in-one formula has obvious effects on building the human body normal intestinal surface mucus layer barrier, terminating inflammation and repairing intestinal tissues, and is an effective formula for treating inflammatory bowel disease.

The invention discloses a composition for treating the inflammatory bowel disease, and belongs to the field of medicines. The composition comprises Mythic Fungus, Salvia miltiorrhiza, ginseng, Poria cocos, glutamine, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene. Mythic Fungus, Salvia miltiorrhiza, ginseng and Poria cocos have the efficacy of enhancing human body blood supply and oxygen supply; glutamine is the main energy source of intestinal mucosa; threonine, serine and cysteine are composition parts of mucoproteins; and vitamin C, vitamin E, vitamin A and beta-carotene have oxyradical activation repression, oxyradical removal and human body cell protection effects. The composition provides nutrition, oxygen and raw materials for generation, updating and restoration of goblet cells and an intestinal tract surface mucus layer barrier composed of mucoproteins secreted by the goblet cells. The composition has obvious inflammation termination, intestinal tract tissue restoration and human body normal intestinal tract surface mucus layer barrier construction effects, and is an effective composition for treating the inflammatory bowel disease.

The invention discloses a combination formula for treating inflammatory bowel disease, and belongs to the field of drugs. The principle of the formula lies in that abnormal immune response and inflammation are prevented by reinforcing intestinal epithelial goblet cells, constructing a normal intestinal tract surface mucous layer barrier, as well as preventing intestine antigen from getting close to, being in contact with, being adhered to, and entering intestinal tissues; ganoderma lucidum has the efficacies of strengthening human body blood supply and human body oxygen supply; L-threonine is the constituent part of mucoprotein and essential amino-acid of the human body, and glutamine is the main energy source of intestinal mucosa. The combination formula provided by the invention provides nutrients, oxygen and raw materials for goblet cells for development, renewal and repairing as well as secretion of mucoprotein to form the intestinal tract surface mucous layer barrier; the three-in-one formula further has obvious effects of constructing the normal human body intestinal tract surface mucous layer barrier, eliminating inflammation and repairing intestinal tissues, thereby being an effective formula for treating inflammatory bowel disease.

The invention discloses a composition for treating the inflammatory bowel disease, and belongs to the field of medicines. The composition comprises Mythic Fungus, ginseng, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene. Mythic Fungus and ginseng have the efficacy of enhancing human body blood supply and oxygen supply; threonine, serine and cysteine are composition parts of mucoproteins; and vitamin C, vitamin E, vitamin A and beta-carotene have oxyradical activation repression, oxyradical removal and human body cell protection effects. The composition provides nutrition, oxygen and raw materials for generation, updating and restoration of goblet cells and an intestinal tract surface mucus layer barrier composed of mucoproteins secreted by the goblet cells. The composition has obvious inflammation termination, intestinal tract tissue restoration and human body normal intestinal tract surface mucus layer barrier construction effects, and is an effective composition for treating the inflammatory bowel disease.

The invention discloses a combination formula for treating inflammatory bowel disease, and belongs to the field of drugs. The principle of the formula lies in that abnormal immune response and inflammation are prevented by reinforcing intestinal epithelial goblet cells, constructing a normal intestinal tract surface mucous layer barrier, as well as preventing intestine antigen from getting close to, being in contact with, being adhered to, and entering intestinal tissues; both ganoderma lucidum and radix salviae miltiorrhizae have the efficacies of strengthening human body blood supply and human body oxygen supply; glutamine is the main energy source of intestinal mucosa. The combination formula provided by the invention provides nutrients, oxygen and raw materials for goblet cells for development, renewal and repairing as well as secretion of mucoprotein to form the intestinal tract surface mucous layer barrier, and further has obvious effects of constructing the normal human body intestinal tract surface mucous layer barrier, eliminating inflammation and repairing intestinal tissues, thereby being an effective formula for treating inflammatory bowel disease.

The invention discloses a composition for treating the inflammatory bowel disease, and belongs to the field of medicines. Intestinal epidermal goblet cells are reinforced to construct a normal intestinal surface mucus layer barrier in order to prevent intestinal antigens from approaching, contacting, adhering and entering intestine wall tissues, so abnormal immune response and inflammation generation are blocked out. Salvia miltiorrhiza has the efficacy of enhancing human body blood supply and oxygen supply; and threonine, serine and cysteine are main composition parts of mucoproteins. The composition provides nutrition, oxygen and raw materials for generation, updating and restoration of goblet cells and an intestinal tract surface mucus layer barrier composed of mucoproteins secreted by the goblet cells. The composition has obvious inflammation termination, intestinal tract tissue restoration and human body normal intestinal tract surface mucus layer barrier construction effects, and is an effective formula for treating the inflammatory bowel disease.